Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Kelemen

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Parasitology Research|May 16, 2014
Life cycles of three Myxobolus spp. from cyprinid fishes of Lake Balaton, Hungary involve triactinomyxon-type actinosporesCsaba Székely, Muhammad Hafiz Borkhanuddin, Gábor Cech, et al.
Gene|August 23, 2012
Function of alternative splicingOlga Kelemen, Paolo Convertini, Zhaiyi Zhang, et al.
Journal of Translational Medicine|August 27, 2025
GeneBits: ultra-sensitive tumour-informed ctDNA monitoring of treatment response and relapse in cancer patientsJulian Broche, Olga Kelemen, Aishwarya Sekar, et al.
Nucleic Acids Research|January 3, 2012
C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1Chiranthani Sumanasekera, Olga Kelemen, Monique Beullens, et al.
Clinical and Translational Radiation Oncology|December 13, 2024
Tumor sequencing before and after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: Genetic tumor characterization and clinical outcomeKerstin Clasen, Nadja Ballin, Leon Schütz, et al.
Clinical and Translational Medicine|June 15, 2020
Proteomic analysis enables distinction of early- versus advanced-stage lung adenocarcinomasOlga Kelemen, Indira Pla, Aniel Sanchez, et al.
Radiation Oncology (London, England)|November 7, 2024
Dynamics of cell-free tumor DNA correlate with early MRI response during chemoradiotherapy in rectal cancerKerstin Clasen, Cihan Gani, Leon Schuetz, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2022
TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapyJulia Eckardt, Christopher Schroeder, Peter Martus, et al.
The Journal of Biological Chemistry|January 12, 2011
Synthesis and characterization of pseudocantharidins, novel phosphatase modulators that promote the inclusion of exon 7 into the SMN (survival of motoneuron) pre-mRNAZhaiyi Zhang, Olga Kelemen, Maria A van Santen, et al.
Nature Communications|October 9, 2024
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibitionChristopher Schroeder, Sergios Gatidis, Olga Kelemen, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Parasitology Research|May 16, 2014
Life cycles of three Myxobolus spp. from cyprinid fishes of Lake Balaton, Hungary involve triactinomyxon-type actinosporesCsaba Székely, Muhammad Hafiz Borkhanuddin, Gábor Cech, et al.
Gene|August 23, 2012
Function of alternative splicingOlga Kelemen, Paolo Convertini, Zhaiyi Zhang, et al.
Journal of Translational Medicine|August 27, 2025
GeneBits: ultra-sensitive tumour-informed ctDNA monitoring of treatment response and relapse in cancer patientsJulian Broche, Olga Kelemen, Aishwarya Sekar, et al.
Nucleic Acids Research|January 3, 2012
C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1Chiranthani Sumanasekera, Olga Kelemen, Monique Beullens, et al.
Clinical and Translational Radiation Oncology|December 13, 2024
Tumor sequencing before and after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: Genetic tumor characterization and clinical outcomeKerstin Clasen, Nadja Ballin, Leon Schütz, et al.
Clinical and Translational Medicine|June 15, 2020
Proteomic analysis enables distinction of early- versus advanced-stage lung adenocarcinomasOlga Kelemen, Indira Pla, Aniel Sanchez, et al.
Radiation Oncology (London, England)|November 7, 2024
Dynamics of cell-free tumor DNA correlate with early MRI response during chemoradiotherapy in rectal cancerKerstin Clasen, Cihan Gani, Leon Schuetz, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2022
TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapyJulia Eckardt, Christopher Schroeder, Peter Martus, et al.
The Journal of Biological Chemistry|January 12, 2011
Synthesis and characterization of pseudocantharidins, novel phosphatase modulators that promote the inclusion of exon 7 into the SMN (survival of motoneuron) pre-mRNAZhaiyi Zhang, Olga Kelemen, Maria A van Santen, et al.
Nature Communications|October 9, 2024
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibitionChristopher Schroeder, Sergios Gatidis, Olga Kelemen, et al.
Pageof 2